Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emerald Health Therapeutics Inc TBQBF


Primary Symbol: EMHTF

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.


OTCQB:EMHTF - Post by User

Post by cannhealthon May 02, 2018 11:48am
97 Views
Post# 27970435

Seems the market, as with all dilutive acquisitions..

Seems the market, as with all dilutive acquisitions..
isn't 100 stoked by this deal. While I'm sure mngmt has their reasons for paying what they did, I still believe it's incumbent on them to elaborate; Why this La Belle Provance company and why 90MM? Dilution will amount to approx 10MM shares of the float. Not bad by any means given the float currently sits at 76MM and change. Notwithstanding.. why them and why 90MM?
Bullboard Posts